Citadel Advisors
ZURA icon

Citadel Advisors’s Zura Bio ZURA Stock Holding History

Citadel Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,300
Closed -$90.7K – 14433
2025
Q4 		$90.7K Sell
17,300
-23,100
-57% -$91.3K ﹤0.01% 11716
2025
Q3 		$175K Buy
+40,400
New +$72.7K ﹤0.01% 11399
2025
Q2 		– Sell
-200
Closed -$258 – 15461
2025
Q1 		$258 Sell
200
-9,100
-98% -$14.4K ﹤0.01% 14300
2024
Q4 		$23.3K Buy
9,300
+7,300
+365% +$26K ﹤0.01% 13080
2024
Q3 		$8.12K Buy
+2,000
New +$7.47K ﹤0.01% 13321

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Citadel Advisors's ZURA Position: Q2 2026 in Review

Citadel Advisors increased its Zura Bio (ZURA) stake by 1,580% in Q2 2026, buying an estimated $1.35M and bringing the position to 300,719 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #6838.

Citadel Advisors first reported a position in ZURA in Q2 2023 and has held it in 11 quarters since. The position peaked at $5.55M in Q2 2023. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Citadel Advisors held 300,719 shares of Zura Bio worth $1.77M as of Q2 2026.
  • Citadel Advisors bought 282,821 Zura Bio shares in Q2 2026, an estimated $1.35M.
  • Zura Bio made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6838 holding.
  • Citadel Advisors first reported a position in Zura Bio in Q2 2023 and has held it in 11 quarters since.
  • Citadel Advisors's Zura Bio position peaked at $5.55M in Q2 2023.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.